IMS webinar - After the IMS World Congress 2024
Your queries, dilemmas and tricky questions answered
Following the 19th IMS World Congress on Menopause in Melbourne in October, the topic of menopause has remained firmly in the spotlight. As the number of evidence-based guidelines has grown, so has consumer health literacy and a wide range of clinical practices promoted by various stakeholders in the menopause space.
The 19th World Congress afforded Australian healthcare providers the opportunity to explore best-practice menopause care recommendations, and our hive mind has been buzzing with a range of opinions related to risk vs benefit of MHT, new and emerging non-MHT treatment options, alongside the most effective ways of conveying evidence-based information to women in our ongoing efforts to counter information overload and misinformation. In addition, we have had the exciting announcements of new dosage options now available for existing MHT formulations, as well as new additions to the PBS list for MHT, offering a wider choice for women.
Additionally, the AMS webinar is designed as a wrap-up of expert opinion, the menopause toolkit, and best-practice recommendations for menopause management, based on the diversity of the expert presentations at the 19th World IMS Congress a few months ago, and the IMS White Paper.
- Download webinar flyer under the RESOURCES tab above
Date and Time
18 March 2025 6.00-7.30pm AEDT
Speakers
Professor Rodney Baber AM
Dr Terri Foran
Dr Elina Safro - Moderator
RACGP Points
RACGP activity no: 1144524
Event Learning outcomes
1. Describe the different non-hormonal treatment options to manage symptoms of menopause.
2. Assess the risks and benefits of initiating, continuing or ceasing/not initiating MHT and non-MHT.
3. Describe the most effective ways of conveying evidence-based information on menopause to counter information overload and misinformation.
4. Assess the new and emerging non-MHT treatment options on the PBS.
Attending the webinar RACGP hours:
Educational Activities: 1.5 HOURS
After the webinar RACGP hours:
Measuring Outcomes: 5 HOURS
Reviewing Performance: 2 HOURS
After the webinar, participants will be invited to complete a mini audit over a three-month window.
RACGP hours for the mini audit:
The audit will involve reviewing the consultations of 10-20 patients from the past 12 months. Participants will assess whether discussions on the benefits and risks of initiating, continuing, ceasing, or not starting Menopausal Hormone Therapy (MHT) and non-MHT options have taken place, and whether these discussions have been documented. Patients who have not had these conversations will be flagged for further review.
Participants will then be encouraged to follow up on these findings, integrating best-practice approaches from the IMS World Congress (Figure 1. Implementing guidance from the 19th World Congress on Menopause into routine clinical practice).
Finally, participants will reflect on their practice to ensure they can apply these best practices in future consultations.
Dr Safro is a general practitioner with expertise in sexual and reproductive health and more than 12 years clinical experience across the full procedural scope in this area of medicine. She also serves as Chair, Education Subcommittee of the Board of AMS and as an Adjunct Research Fellow at the HER Centre, Monash University.
Dr Terri Foran is a Sexual Health Physician with a special clinical interest in contraception, menopause and the management of sexually transmitted infections. She has had numerous publications in these fields. Dr Foran holds the position of Conjoint Senior Lecturer in the School of Women’s and Children’s Health at UNSW Sydney, where she is regularly involved in the teaching of undergraduate students. She has worked in both private and public clinical practice, most recently as a Visiting Medical Officer at the Menopause Hub established at the Royal Hospital for Women in Randwick. She is a current Board member of the Australasian Menopause Society. She also has a particular interest in postgraduate clinical education and has presented at both National and International conferences as well as hosting regular podcasts for HealthEd on topics related to sexual and reproductive health.
Clinical Professor of Obstetrics and Gynaecology at Sydney Medical School, University of Sydney, Professor Rod Baber is Past President of the International Menopause Society. He studied Pharmacy and then Medicine at the University of Sydney. He completed specialist training in Obstetrics and Gynaecology at Australia’s Royal North Shore Hospital and in the UK at Kings College Hospital and the Lister Fertility and Endocrinology Centre. Professor Baber holds a Fellowship of both the Royal and Royal Australian & New Zealand Colleges of Obstetricians and Gynaecologists. He holds specialist appointments at North Shore Private and the Mater Hospitals in Sydney, is a visiting medical officer at the Royal North Shore Hospital and has a practice specialising in gynaecology in St Leonards.
